Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region K.B. Laupland, D.B. Gregson, D.L. Church,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Gut bacterial microbiota and obesity

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

U.S. Jensen, J.D. Knudsen, S. Wehberg, D.B. Gregson, K.B. Laupland

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland M. Eklund, M. Bielaszewska, U.-M. Nakari,

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre.

Nocardiosis in Quebec, Canada, 1988–2008

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.

Clinical Microbiology and Infection

Escherichia coli native valve endocarditis

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

D.E. Low Clinical Microbiology and Infection

Vector control: a cornerstone in the malaria elimination campaign

Gilaad G. Kaplan, Daniel B. Gregson, Kevin B. Laupland

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Sofie Arens, Jan Verhaegen, Ludo Verbist

M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour

B. Gordts Clinical Microbiology and Infection

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini,

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region K.B. Laupland, M.D. Parkins, T. Ross, J.D.D. Pitout

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

C. Gagliotti, L. Nobilio, M.L. Moro

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

An after-hours clinical liaison blood culture service—is it worth it?

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

C. Novais, T.M. Coque, J.C. Sousa, L.V. Peixe

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

W. Witte Clinical Microbiology and Infection

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases

Are we losing the fight against malaria one more time?

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region K.B. Laupland, D.B. Gregson, D.L. Church, T. Ross, J.D.D. Pitout Clinical Microbiology and Infection Volume 14, Issue 11, Pages 1041-1047 (November 2008) DOI: 10.1111/j.1469-0691.2008.02089.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Annual incidence of Escherichia coli bloodstream infections in the Calgary Health Region, Canada, 2000–2006. CA, community-acquired; HCA, healthcare-associated community-onset; NA, nosocomial-acquired. Clinical Microbiology and Infection 2008 14, 1041-1047DOI: (10.1111/j.1469-0691.2008.02089.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Age-specific incidence of Escherichia coli bloodstream infections in the Calgary Health Region, Canada, 2000–2006. Clinical Microbiology and Infection 2008 14, 1041-1047DOI: (10.1111/j.1469-0691.2008.02089.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Rates of antimicrobial resistance among Escherichia coli isolates from bloodstream infections in the Calgary Health Region, Canada, 2000–2006. TMP/SMX, trimethoprim–sulphamethoxazole. Clinical Microbiology and Infection 2008 14, 1041-1047DOI: (10.1111/j.1469-0691.2008.02089.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions